Steroid Nasal Spray for Sleep Disordered Breathing in Childre

Phase 2

Recruiting

• Conditions: Sleep Disordered Breathing; Respiratory - Sleep apnoea

• Registration Number: ACTRN12618000448246
• Lead Sponsor: Murdoch Children's Research Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-03-28
• Last Update Posted: 30 September 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 276

Inclusion Criteria

Patients aged 3 to 12 years of age, referred to Upper Airways, Sleep, Respiratory and Ear Nose Throat (ENT) clinics at the Royal Children’s Hospital (RCH) and Sleep and ENT clinic at Monash Medical Centre (MMC) will be screened by telephone for symptoms of SDB
•Children with a Brouillette score =/> -1 will be eligible

Exclusion Criteria

Children will be excluded if:
•BMI > 97th centile
•Stertor while awake and at rest
•Past Tonsillectomy and/or Adenoidectomy
•Craniofacial, neuromuscular, syndromic or defined genetic disorders
•Haemorrhagic diathesis or recurrent nosebleeds
•Use of intranasal or systemic corticosteroid within the past 6 weeks
•Active nasal infection or nasal trauma not fully healed
•Active tonsillitis

Study & Design

• Study Type: Interventional
• Study Design: Not specified